337 related articles for article (PubMed ID: 28906430)
1. Identification of a Novel Inhibitor against Middle East Respiratory Syndrome Coronavirus.
Sun Y; Zhang H; Shi J; Zhang Z; Gong R
Viruses; 2017 Sep; 9(9):. PubMed ID: 28906430
[TBL] [Abstract][Full Text] [Related]
2. Protective Effect of Intranasal Regimens Containing Peptidic Middle East Respiratory Syndrome Coronavirus Fusion Inhibitor Against MERS-CoV Infection.
Channappanavar R; Lu L; Xia S; Du L; Meyerholz DK; Perlman S; Jiang S
J Infect Dis; 2015 Dec; 212(12):1894-903. PubMed ID: 26164863
[TBL] [Abstract][Full Text] [Related]
3. [Development of peptidic MERS-CoV entry inhibitors].
Xia S; Wang Q; Liu SW; Lu L; Jiang SB
Yao Xue Xue Bao; 2015 Dec; 50(12):1513-9. PubMed ID: 27169270
[TBL] [Abstract][Full Text] [Related]
4. Potent MERS-CoV Fusion Inhibitory Peptides Identified from HR2 Domain in Spike Protein of Bat Coronavirus HKU4.
Xia S; Lan Q; Pu J; Wang C; Liu Z; Xu W; Wang Q; Liu H; Jiang S; Lu L
Viruses; 2019 Jan; 11(1):. PubMed ID: 30646495
[TBL] [Abstract][Full Text] [Related]
5. MERS-CoV spike protein: a key target for antivirals.
Du L; Yang Y; Zhou Y; Lu L; Li F; Jiang S
Expert Opin Ther Targets; 2017 Feb; 21(2):131-143. PubMed ID: 27936982
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Hydrocarbon-Stapled Short α-Helical Peptides as Promising Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Fusion Inhibitors.
Wang C; Xia S; Zhang P; Zhang T; Wang W; Tian Y; Meng G; Jiang S; Liu K
J Med Chem; 2018 Mar; 61(5):2018-2026. PubMed ID: 29442512
[TBL] [Abstract][Full Text] [Related]
7. Structure-based discovery of Middle East respiratory syndrome coronavirus fusion inhibitor.
Lu L; Liu Q; Zhu Y; Chan KH; Qin L; Li Y; Wang Q; Chan JF; Du L; Yu F; Ma C; Ye S; Yuen KY; Zhang R; Jiang S
Nat Commun; 2014; 5():3067. PubMed ID: 24473083
[TBL] [Abstract][Full Text] [Related]
8. Novel Gold Nanorod-Based HR1 Peptide Inhibitor for Middle East Respiratory Syndrome Coronavirus.
Huang X; Li M; Xu Y; Zhang J; Meng X; An X; Sun L; Guo L; Shan X; Ge J; Chen J; Luo Y; Wu H; Zhang Y; Jiang Q; Ning X
ACS Appl Mater Interfaces; 2019 Jun; 11(22):19799-19807. PubMed ID: 31099550
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of Coronavirus Entry
Outlaw VK; Bovier FT; Mears MC; Cajimat MN; Zhu Y; Lin MJ; Addetia A; Lieberman NAP; Peddu V; Xie X; Shi PY; Greninger AL; Gellman SH; Bente DA; Moscona A; Porotto M
mBio; 2020 Oct; 11(5):. PubMed ID: 33082259
[TBL] [Abstract][Full Text] [Related]
10. Structure of the fusion core and inhibition of fusion by a heptad repeat peptide derived from the S protein of Middle East respiratory syndrome coronavirus.
Gao J; Lu G; Qi J; Li Y; Wu Y; Deng Y; Geng H; Li H; Wang Q; Xiao H; Tan W; Yan J; Gao GF
J Virol; 2013 Dec; 87(24):13134-40. PubMed ID: 24067982
[TBL] [Abstract][Full Text] [Related]
11. Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.
Zhu Y; Yu D; Yan H; Chong H; He Y
J Virol; 2020 Jul; 94(14):. PubMed ID: 32376627
[TBL] [Abstract][Full Text] [Related]
12. Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies.
Li J; Li Q; Xia S; Tu J; Zheng L; Wang Q; Jiang S; Wang C
Bioorg Med Chem Lett; 2024 Jan; 97():129569. PubMed ID: 38008340
[TBL] [Abstract][Full Text] [Related]
13. Design and characterization of human respiratory syncytial virus entry inhibitors.
Ni L; Zhao L; Qian Y; Zhu J; Jin Z; Chen YW; Tien P; Gao GF
Antivir Ther; 2005; 10(7):833-40. PubMed ID: 16312179
[TBL] [Abstract][Full Text] [Related]
14. Identification of a peptide derived from the heptad repeat 2 region of the porcine epidemic diarrhea virus (PEDV) spike glycoprotein that is capable of suppressing PEDV entry and inducing neutralizing antibodies.
Zhao P; Wang B; Ji CM; Cong X; Wang M; Huang YW
Antiviral Res; 2018 Feb; 150():1-8. PubMed ID: 29203391
[TBL] [Abstract][Full Text] [Related]
15. MERS-CoV spike protein: Targets for vaccines and therapeutics.
Wang Q; Wong G; Lu G; Yan J; Gao GF
Antiviral Res; 2016 Sep; 133():165-77. PubMed ID: 27468951
[TBL] [Abstract][Full Text] [Related]
16. Ca
Straus MR; Tang T; Lai AL; Flegel A; Bidon M; Freed JH; Daniel S; Whittaker GR
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295925
[TBL] [Abstract][Full Text] [Related]
17. Middle East respiratory syndrome coronavirus (MERS-CoV) entry inhibitors targeting spike protein.
Xia S; Liu Q; Wang Q; Sun Z; Su S; Du L; Ying T; Lu L; Jiang S
Virus Res; 2014 Dec; 194():200-10. PubMed ID: 25451066
[TBL] [Abstract][Full Text] [Related]
18. Species-Specific Colocalization of Middle East Respiratory Syndrome Coronavirus Attachment and Entry Receptors.
Widagdo W; Okba NMA; Li W; de Jong A; de Swart RL; Begeman L; van den Brand JMA; Bosch BJ; Haagmans BL
J Virol; 2019 Aug; 93(16):. PubMed ID: 31167913
[TBL] [Abstract][Full Text] [Related]
19. Spread of Mutant Middle East Respiratory Syndrome Coronavirus with Reduced Affinity to Human CD26 during the South Korean Outbreak.
Kim Y; Cheon S; Min CK; Sohn KM; Kang YJ; Cha YJ; Kang JI; Han SK; Ha NY; Kim G; Aigerim A; Shin HM; Choi MS; Kim S; Cho HS; Kim YS; Cho NH
mBio; 2016 Mar; 7(2):e00019. PubMed ID: 26933050
[TBL] [Abstract][Full Text] [Related]
20. An engineered 5-helix bundle derived from SARS-CoV-2 S2 pre-binds sarbecoviral spike at both serological- and endosomal-pH to inhibit virus entry.
Lin X; Guo L; Lin S; Chen Z; Yang F; Yang J; Wang L; Wen A; Duan Y; Zhang X; Dai Y; Yin K; Yuan X; Yu C; He B; Cao Y; Dong H; Li J; Zhao Q; Lu G
Emerg Microbes Infect; 2022 Dec; 11(1):1920-1935. PubMed ID: 35757908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
